{
    "ids": [
        [
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-ARTICLE VII TERMINATION-58",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Effect of Termination-60",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Termination or Abandonment-59",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Termination of the Merger Agreement-32",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Termination of the Merger Agreement-10",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Termination Fees-11",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Parent Termination Fee-62",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Termination Fees-33",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Company Termination Fee-61",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Enforcement Expenses-12"
        ],
        [
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Legal Proceedings Regarding the Merger-4",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Legal Proceedings Regarding the Merger-19",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Taxes-41"
        ],
        [
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Entire Agreement-65",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Access to Information-29",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Access-47",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Intellectual Property-43",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Alternative Acquisition Agreements-6",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Public Announcements-52",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Annex A\u2003Agreement and Plan of Merger-38",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Restrictions on Solicitations of Other Offers-5",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Explanatory Note Regarding the Merger Agreement-20",
            "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf-Adverse Recommendation Changes-25"
        ]
    ],
    "distances": [
        [
            0.3079279065132141,
            0.35404521226882935,
            0.3617878258228302,
            0.3705000877380371,
            0.3716534972190857,
            0.37539443373680115,
            0.38482922315597534,
            0.38600394129753113,
            0.39210739731788635,
            0.3945070207118988
        ],
        [
            0.4607647657394409,
            0.46186456084251404,
            0.46394458413124084
        ],
        [
            0.3872058093547821,
            0.40671655535697937,
            0.4259062111377716,
            0.44325175881385803,
            0.4613412022590637,
            0.462764173746109,
            0.4719558358192444,
            0.4733245074748993,
            0.48254844546318054,
            0.5276150107383728
        ]
    ],
    "metadatas": [
        [
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 157,
                "Keyword": "Termination",
                "Section Header": "ARTICLE VII TERMINATION",
                "Start Page": 157
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 158,
                "Keyword": "Termination",
                "Section Header": "Effect of Termination",
                "Start Page": 158
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 158,
                "Keyword": "Termination",
                "Section Header": "Termination or Abandonment",
                "Start Page": 157
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 98,
                "Keyword": "Termination",
                "Section Header": "Termination of the Merger Agreement",
                "Start Page": 96
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 23,
                "Keyword": "Termination",
                "Section Header": "Termination of the Merger Agreement",
                "Start Page": 21
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 23,
                "Keyword": "Termination",
                "Section Header": "Termination Fees",
                "Start Page": 23
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 160,
                "Keyword": "Termination",
                "Section Header": "Parent Termination Fee",
                "Start Page": 160
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 98,
                "Keyword": "Termination",
                "Section Header": "Termination Fees",
                "Start Page": 98
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 160,
                "Keyword": "Termination",
                "Section Header": "Company Termination Fee",
                "Start Page": 158
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 24,
                "Keyword": "Termination",
                "Section Header": "Enforcement Expenses",
                "Start Page": 23
            }
        ],
        [
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 18,
                "Keyword": "Indemnification",
                "Section Header": "Legal Proceedings Regarding the Merger",
                "Start Page": 17
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 76,
                "Keyword": "Indemnification",
                "Section Header": "Legal Proceedings Regarding the Merger",
                "Start Page": 76
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 129,
                "Keyword": "Indemnification",
                "Section Header": "Taxes",
                "Start Page": 128
            }
        ],
        [
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 164,
                "Keyword": "Confidentiality",
                "Section Header": "Entire Agreement",
                "Start Page": 164
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 94,
                "Keyword": "Confidentiality",
                "Section Header": "Access to Information",
                "Start Page": 93
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 142,
                "Keyword": "Confidentiality",
                "Section Header": "Access",
                "Start Page": 142
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 132,
                "Keyword": "Confidentiality",
                "Section Header": "Intellectual Property",
                "Start Page": 131
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 19,
                "Keyword": "Confidentiality",
                "Section Header": "Alternative Acquisition Agreements",
                "Start Page": 18
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 150,
                "Keyword": "Confidentiality",
                "Section Header": "Public Announcements",
                "Start Page": 150
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 117,
                "Keyword": "Confidentiality",
                "Section Header": "Annex A\u2003Agreement and Plan of Merger",
                "Start Page": 113
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 18,
                "Keyword": "Confidentiality",
                "Section Header": "Restrictions on Solicitations of Other Offers",
                "Start Page": 18
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 77,
                "Keyword": "Confidentiality",
                "Section Header": "Explanatory Note Regarding the Merger Agreement",
                "Start Page": 76
            },
            {
                "Document": "TIVITY HEALTH, INC._20220524_DEFM14A_20120335_4468156.Pdf",
                "End Page": 89,
                "Keyword": "Confidentiality",
                "Section Header": "Adverse Recommendation Changes",
                "Start Page": 88
            }
        ]
    ],
    "documents": [
        [
            "ARTICLE VII\nTERMINATION",
            "Section 7.2 Effect of Termination. In the event of termination of this Agreement pursuant to and in accordance with\nSection 7.1, this Agreement shall terminate and become void and of no effect (except that the Confidentiality\nAgreement and the provisions of Section 3.26, Section 4.16, Section 5.2(d), this Section 7.2, Section 7.3, Section 7.4\nand ARTICLE VIII shall survive any termination), and there shall be no other liability on the part of the Company, on\nthe one hand, or Parent or Merger Sub, on the other hand, to the other except as provided in Section 7.3 and Section\n7.4\u037e provided, however, that, subject to Section 7.3 and Section 7.4, if such termination shall result from the Willful\nand Material Breach of any provision of this Agreement or any Fraud by any Party, such Party shall not be relieved\nor released from any liabilities or damages arising out of its Willful and Material Breach of any provision of this\nAgreement or its Fraud. Notwithstanding anything in this Agreement to the contrary, in no event shall the Parent\nRelated Parties have any monetary liability or obligations under this Agreement in the event this Agreement is validly\nterminated pursuant to Section 7.1, (including any monetary liability or obligation pursuant to Section 5.19, Section\n5.20, this Section 7.2 and Section 7.3) in the aggregate amount greater than the Parent Termination Fee plus the\nEnforcement Expenses pursuant to Section 7.4. The Parties acknowledge and agree that nothing in this Section 7.2,\nSection 7.3(c) or Section 7.4(c) shall be deemed to affect their right to specific performance under Section 8.5.\nSection 7.3",
            "Section 7.1 Termination or Abandonment. Notwithstanding anything in this Agreement to the contrary, this\nAgreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time, only as\nfollows, and subject to any required authorizations of the Company Board of Directors or the board of directors of\nMerger Sub to the extent required by the DGCL, as applicable (and notwithstanding the adoption of this Agreement\nby Parent as the sole stockholder of Merger Sub):\n(a) by the mutual written consent of the Company and Parent\u037e\n(b) by either the Company or Parent, if the Company Stockholder Approval shall not have been obtained upon\na vote taken thereon at the Company Stockholder Meeting or at any adjournment or postponement thereof\u037e\n(c) by either the Company or Parent if the Closing shall not have occurred on or prior to 12:01 a.m., New York\nCity time, on October 5, 2022 (such date, the \u201cEnd Date\u201d), whether such date is before or after the date of the\nreceipt of Company Stockholder Approval\u037e provided, however, that the right to terminate this Agreement\npursuant to this Section 7.1(c) may not be exercised by any party whose failure to perform any covenant or\nobligation under this Agreement has been the principal cause of, or resulted in, the failure of the Closing to have\noccurred on or before the End Date\u037e\n(d) by either the Company or Parent if an Order by a Governmental Entity of competent jurisdiction shall have\nbeen issued permanently restraining, enjoining or otherwise prohibiting the consummation of the Merger and\nsuch Order shall have become final and nonappealable\u037e provided, however, that the right to terminate this\nAgreement under this Section 7.1(d) shall not be available to a Party if such Order (or such Order becoming final\nand nonappealable) was due to the material breach of such Party of any representation, warranty, covenant or\nagreement of such Party set forth in this Agreement\u037e\n(e) by the Company (provided, that the Company is not then in breach of any representation, warranty,\ncovenant or other agreement contained herein such that any condition set forth in Section 6.2(a) or\nA-45TABLE OF CONTENTS\nSection 6.2(b) would not be satisfied) if: (A) Parent or Merger Sub shall have breached or failed to perform any\nof their covenants, representations or warranties contained in this Agreement, which breach or failure to perform\n(A) would give rise to the failure of any condition set forth in Section 6.3(a) or Section 6.3(b)\u037e and (B) the\nrelevant breaches, failures to perform or inaccuracies referred to in clause (A) of this Section 7.1(e) is or are\neither not curable or is not cured by the earlier of (x) the End Date and (y) the date that is thirty (30) calendar\ndays following written notice from the Company to Parent describing such breach or failure or inaccuracy in\nreasonable detail\u037e\n(f) by the Company, prior to obtaining the Company Stockholder Approval, in accordance with Section 5.5(e)\nin order to enter into a definitive agreement providing for a Company Superior Proposal (after compliance in all\nmaterial respects with the terms of Section 5.5) either concurrently with or immediately following such\ntermination\u037e provided, that immediately prior to or concurrently with (and as a condition to) the termination of\nthis Agreement, the Company pays to Parent the Termination Fee in the manner provided in Section 7.3(a)\u037e\n(g) by Parent (provided, that Parent is not then in breach of any representation, warranty, covenant or other\nagreement contained herein such that any condition set forth in Section 6.3(a) or Section 6.3(b) would not be\nsatisfied), if (A) the Company shall have breached or failed to perform any of its representations, warranties,\ncovenants or other agreements contained in this Agreement, which breach or failure to perform, if it occurred or\nwas continuing to occur at the Effective Time, would result in a failure of a condition set forth in Section 6.2(a) or\nSection 6.2(b), and (B) the relevant breaches, failures to perform or inaccuracies referred to in clause (A) of this\nSection 7.1(g) is or are not curable or is not cured by the earlier of (x) the End Date and (y) the date that is thirty\n(30) days following written notice from Parent to the Company describing such breach or failure in reasonable\ndetail\u037e\n(h) by Parent if, prior to obtaining the Company Stockholder Approval, a Company Adverse Recommendation\nChange shall have occurred\u037e and\n(i) by the Company, if (i) all of the conditions set forth in Section 6.1 and Section 6.2 (other than conditions\nwhich are to be satisfied by actions taken at the Closing, but which shall then be capable of satisfaction if the\nClosing were to occur on such date) have been and continue to be satisfied, (ii) the Company has notified\nParent in writing that all of the conditions set forth in Section 6.1 and Section 6.2 have been satisfied or, with\nrespect to the conditions set forth in Section 6.2, validly waived (or would be satisfied or validly waived if the\nClosing were to occur on the date of such notice and other than the conditions set forth in Section 6.1 which\nmay not be waived by any party) and it stands ready, willing and able to consummate the Merger at such time,\n(iii) the Company shall have given Parent written notice at least three (3) Business Days prior to such\ntermination stating that the Company\u2019s intention is to terminate this Agreement pursuant to this Section 7.1(i)\nand (iv) Parent fails to consummate the Closing at the end of such three (3) Business Day period.",
            "Termination of the Merger Agreement\nThe Merger Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time,\nonly as follows, and subject to any required authorizations of the Board or the board of directors of Merger Sub to\nthe extent required by the DGCL, as applicable:\n\u2022\nby mutual written consent of Tivity Health and Parent\u037e\n\u2022\nby either Tivity Health or Parent, if:\n\u2022\nthe Tivity Health Stockholder Approval is not obtained upon a vote taken thereon at the Stockholder\nMeeting or at any adjournment or postponement thereof\u037e\n\u2022\nthe closing of the Merger has not occurred on or prior to the End Date, whether such date is before or\nafter the date of the receipt of the Tivity Health Stockholder Approval\u037e provided, however, that this\nright to terminate the Merger Agreement may not be exercised by any party whose failure to perform\nany covenant or obligation under the Merger Agreement has been the principal cause of, or resulted\nin, the failure of the closing of the Merger to have occurred on or prior to the End Date\u037e or\n\u2022\nan order by a governmental entity of competent jurisdiction has been issued permanently restraining,\nenjoining or otherwise prohibiting the consummation of the Merger and such order has become final\nand nonappealable\u037e provided, however, that this right to terminate the Merger Agreement will not be\navailable to a party if such order (or such order becoming final and nonappealable) was due to the\nmaterial breach of such party of any representation, warranty, covenant or agreement of such party set\nforth in the Merger Agreement.\n86TABLE OF CONTENTS\n\u2022\nby Tivity Health, if:\n\u2022\nParent or Merger Sub has breached or failed to perform any of their covenants, representations or\nwarranties contained in the Merger Agreement, which breach or failure to perform (A) would give rise\nto the failure of any condition to the obligations of Tivity Health to effect the Merger\u037e and (B) the\nrelevant breaches, failures to perform or inaccuracies referred to in clause (A) is or are either not\ncurable or is not cured by the earlier of (x) the End Date and (y) the date that is 30 calendar days\nfollowing written notice from Tivity Health to Parent describing such breach or failure or inaccuracy in\nreasonable detail (provided that Tivity Health is not then in breach of any representation, warranty,\ncovenant or other agreement contained in the Merger Agreement such that any condition to the\nobligations of Parent or Merger Sub to effect the Merger (other than the requirement of an officer\u2019s\ncertificate) would not be satisfied)\u037e\n\u2022\nprior to obtaining the Tivity Health Stockholder Approval, in order to enter into a definitive agreement\nproviding for a Company Superior Proposal (after compliance in all material respects with the\napplicable terms of the Merger Agreement) either concurrently with or immediately following such\ntermination\u037e provided, that immediately prior to or concurrently with (and as a condition to) the\ntermination of the Merger Agreement, Tivity Health pays to Parent the termination fee in the manner\nprovided in the relevant provisions of the Merger Agreement\u037e\n\u2022\n(i) all of the conditions to Parent\u2019s and Merger Sub\u2019s obligations to effect the Merger have been\nsatisfied (other than conditions which are to be satisfied by actions taken at the closing of the Merger,\nbut which will then be capable of satisfaction if the closing of the Merger were to occur on such date)\nhave been and continue to be satisfied, (ii) Tivity Health has notified Parent in writing that all such\nconditions have been satisfied or, with respect to the conditions solely applicable to Parent\u2019s and\nMerger Sub\u2019s obligations to effect the Merger Sub, validly waived (or would be satisfied or validly\nwaived if the closing of the Merger were to occur on the date of such notice and other than the\nconditions applicable to each of Tivity Health\u2019s, Parent\u2019s and Merger Sub\u2019s obligations to effect the\nMerger, which may not be waived by any party) and it stands ready, willing and able to consummate\nthe Merger at such time, (iii) Tivity Health will have given Parent written notice at least three business\ndays prior to such termination stating that Tivity Health\u2019s intention is to terminate the Merger\nAgreement and (iv) Parent fails to consummate the closing of the Merger at the end of such three\nbusiness day period.\n\u2022\nby Parent if:\n\u2022\nTivity Health has breached or failed to perform any of its representations, warranties, covenants or\nother agreements contained in the Merger Agreement, which breach or failure to perform, if it occurred\nor was continuing to occur at the Effective Time, would result in a failure of a condition to the\nobligations of Parent or Merger Sub to effect the Merger (other than the requirement of an officer\u2019s\ncertificate), and such breaches, failures to perform or inaccuracies is or are not curable or is or are not\ncured by the earlier of (x) the End Date and (y) the date that is 30 days following written notice from\nParent to Tivity Health describing such breach or failure in reasonable detail (provided that Parent is\nnot then in breach of any representation, warranty, covenant or other agreement contained in the\nMerger Agreement such that any condition to the obligations of Parent or Merger Sub to effect the\nMerger (other than the requirement of an officer\u2019s certificate) would not be satisfied)\u037e and\n\u2022\nprior to obtaining the Tivity Health Stockholder Approval, a Company Adverse Recommendation\nChange has occurred.\nIn the event of termination of the Merger Agreement pursuant to the relevant provisions thereof, the Merger\nAgreement will terminate and become void and of no effect (except that the confidentiality agreement between the\nparties and the provisions relating to the absence of any other representations or warranties by Tivity Health, Parent\nand Merger Sub, the confidentiality agreement between the parties, the effect of termination, the termination fee, the\nreverse termination fee and certain other procedural provisions will survive any termination), and there will be no\nother liability on the part of Tivity Health, on the one hand, or Parent or Merger Sub, on the other hand, to the other\nexcept as provided in provisions of the Merger Agreement relating to the termination fee and the reverse termination\nfee\u037e provided, however, that, subject those provisions, if such termination should\n87\nTABLE OF CONTENTS\nresult from the willful and material breach of any provision of the Merger Agreement or any fraud by any party, such\nparty will not be relieved or released from any liabilities or damages arising out of its willful and material breach of any\nprovision of the Merger Agreement or its fraud. Notwithstanding anything in the Merger Agreement to the contrary,\nin no event will Parent, Merger Sub, the Guarantors, the financing sources and any of their respective affiliates have\nany monetary liability or obligations under the Merger Agreement in the event it is validly terminated pursuant its\nrelevant provisions (including any monetary liability or obligation pursuant to provisions relating to financing, the\neffect of termination, and the termination fee) in the aggregate amount greater than the reverse termination fee plus\nany enforcement expenses not to exceed $7.5 million.",
            "Termination of the Merger Agreement (page 86)\nThe Merger Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time,\nonly as follows, and subject to any required authorizations of the Board or the board of directors of Merger Sub to\nthe extent required by the DGCL, as applicable:\n1\n1TABLE OF CONTENTS\n\u2022\nby mutual written consent of Tivity Health and Parent\u037e\n\u2022\nby either Tivity Health or Parent, if:\n\u2022\nthe Tivity Health Stockholder Approval is not obtained upon a vote taken thereon at the Stockholder\nMeeting or at any adjournment or postponement thereof\u037e\n\u2022\nthe closing of the Merger has not occurred on or prior to 12:01 a.m., New York City time, on October 5,\n2022 (the \u201cEnd Date\u201d), whether such date is before or after the date of the receipt of Tivity Health\nStockholder Approval\u037e provided, however, that this right to terminate the Merger Agreement may not\nbe exercised by any party whose failure to perform any covenant or obligation under the Merger\nAgreement has been the principal cause of, or resulted in, the failure of the closing of the Merger to\nhave occurred on or prior to the End Date\u037e or\n\u2022\nan order by a governmental entity of competent jurisdiction has been issued permanently restraining,\nenjoining or otherwise prohibiting the consummation of the Merger and such order has become final\nand nonappealable\u037e provided, however, that this right to terminate the Merger Agreement will not be\navailable to a party if such order (or such order becoming final and nonappealable) was due to the\nmaterial breach of such party of any representation, warranty, covenant or agreement of such party set\nforth in the Merger Agreement.\n\u2022\nby Tivity Health, if:\n\u2022\nParent or Merger Sub has breached or failed to perform any of their covenants, representations or\nwarranties contained in the Merger Agreement, which breach or failure to perform (A) would give rise\nto the failure of any condition to the obligations of Tivity Health to effect the Merger\u037e and (B) the\nrelevant breaches, failures to perform or inaccuracies referred to in clause (A) is or are either not\ncurable or is not cured by the earlier of (x) the End Date and (y) the date that is 30 calendar days\nfollowing written notice from Tivity Health to Parent describing such breach or failure or inaccuracy in\nreasonable detail (provided that Tivity Health is not then in breach of any representation, warranty,\ncovenant or other agreement contained in the Merger Agreement such that any condition to the\nobligations of Parent or Merger Sub to effect the Merger (other than the requirement of an officer\u2019s\ncertificate) would not be satisfied)\u037e\n\u2022\nprior to obtaining the Tivity Health Stockholder Approval, in order to enter into a definitive agreement\nproviding for a Company Superior Proposal (after compliance in all material respects with the\napplicable terms of the Merger Agreement) either concurrently with or immediately following such\ntermination\u037e provided, that immediately prior to or concurrently with (and as a condition to) the\ntermination of the Merger Agreement, Tivity Health pays to Parent the termination fee in the manner\nprovided in the relevant provisions of the Merger Agreement\u037e\n\u2022\n(i) all of the conditions to Parent\u2019s and Merger Sub\u2019s obligations to effect the Merger have been\nsatisfied (other than conditions which are to be satisfied by actions taken at the closing of the Merger,\nbut which will then be capable of satisfaction if the closing of the Merger were to occur on such date)\nhave been and continue to be satisfied, (ii) Tivity Health has notified Parent in writing that all such\nconditions have been satisfied or, with respect to the conditions solely applicable to Parent\u2019s and\nMerger Sub\u2019s obligations to effect the Merger Sub, validly waived (or would be satisfied or validly\nwaived if the closing of the Merger were to occur on the date of such notice and other than the\nconditions applicable to each of Tivity Health\u2019s, Parent\u2019s and Merger Sub\u2019s obligations to effect the\nMerger, which may not be waived by any party) and it stands ready, willing and able to consummate\nthe Merger at such time, (iii) Tivity Health will have given Parent written notice at least three business\ndays prior to such termination stating that Tivity Health\u2019s intention is to terminate the Merger\nAgreement and (iv) Parent fails to consummate the closing of the Merger at the end of such three\nbusiness day period.\n\u2022\nby Parent if:\n\u2022\nTivity Health has breached or failed to perform any of its representations, warranties, covenants or\nother agreements contained in the Merger Agreement, which breach or failure to perform, if it occurred\nor was continuing to occur at the Effective Time, would result in a failure of a condition to the\n12\nTABLE OF CONTENTS\nobligations of Parent or Merger Sub to effect the Merger (other than the requirement of an officer\u2019s\ncertificate), and such breaches, failures to perform or inaccuracies is or are not curable or is not cured\nby the earlier of (x) the End Date and (y) the date that is 30 days following written notice from Parent\nto Tivity Health describing such breach or failure in reasonable detail (provided that Parent is not then\nin breach of any representation, warranty, covenant or other agreement contained in the Merger\nAgreement such that any condition to the obligations of Parent or Merger Sub to effect the Merger\n(other than the requirement of an officer\u2019s certificate) would not be satisfied)\u037e and\n\u2022\nprior to obtaining the Tivity Health Stockholder Approval, a Company Adverse Recommendation\nChange has occurred.",
            "Termination Fees (page 88)\nIf the Merger Agreement is terminated in specified circumstances, the terminating party may be required to pay a\ntermination fee.\nParent would be entitled to receive a termination fee of $54,371,114 from Tivity Health if:\n\u2022\nthe Merger Agreement is terminated by Tivity Health to enter into a definitive agreement with respect to a\nCompany Superior Proposal\u037e\n\u2022\nthe Merger Agreement is terminated by Parent because a Company Adverse Recommendation Change has\noccurred prior to obtaining the Tivity Health Stockholder Approval\u037e or\n\u2022\nif (i) a Company Takeover Proposal has been publicly disclosed by any person after April 5, 2022 and not\nwithdrawn prior to a termination of the Merger Agreement as contemplated by its terms and thereafter the\nMerger Agreement is terminated (x) by Parent or Tivity Health because the closing of the Merger has not\noccurred on or prior to the End Date and at the time of such termination the conditions to the parties\u2019\nobligations to effect the Merger relating to the absence of legal prohibitions and the expiration of\napplicable waiting periods under the HSR Act have been satisfied, (y) by Parent because of the breach of\nany representation, warranty, covenant or other agreement under the Merger Agreement by Tivity Health,\nwhich breach would give rise to the failure of any conditions to the obligations of Parent to effect the\nMerger or (z) by Parent or Tivity Health if the Tivity Health Stockholder Approval has not been obtained\nupon a vote taken thereon at the Stockholder Meeting or any adjournment or postponement thereof, and\n(ii) at any time on or prior to the 12 month anniversary of such termination, Tivity Health or any of its\nsubsidiaries enters into a definitive agreement with respect to any transaction included within the definition\nof Company Takeover Proposal that is subsequently consummated (whether within such 12 month period\nor thereafter)\u037e provided, that for the purposes of this provision, all references in the definition of Company\nTakeover Proposal to 20% will instead be references to 50%.\nTivity Health would be entitled to receive a reverse termination fee of $100,377,441 from Parent in the event the\nMerger Agreement is terminated (i) by Tivity Health because of the breach of any representation, warranty, covenant\nor other agreement under the Merger Agreement by Parent and Merger Sub, which breach would give rise to the\nfailure of any conditions to the obligations of Tivity Health to effect the Merger, (ii) by Tivity Health because of\nParent\u2019s failure to consummate the closing of the Merger within three business days of Tivity Health\u2019s notice of the\nsatisfaction or waiver of all conditions to Parent and Merger Sub\u2019s obligations to effect the Merger, Tivity Health\u2019s\nwillingness and ability to effect the Merger at such time, Tivity Health\u2019s intent to terminate the Merger Agreement, or\n(iii) by Tivity Health or Parent because the closing of the Merger has not occurred on or prior to the End Date and, at\nthe time of such termination, Tivity Health would have been entitled to terminate the Merger Agreement under\nclauses (i) or (ii) above.",
            "Section 7.4 Parent Termination Fee.\n(a) If this Agreement is terminated by (x) the Company pursuant to and in accordance with Section 7.1(e) or\nSection 7.1(i) or (y) the Company or Parent pursuant to and in accordance with Section 7.1(c) if, at the time of\nsuch termination, the Company would have been entitled to terminate this Agreement pursuant to Section 7.1(e)\nor Section 7.1(i), Parent shall pay, or cause to be paid, to the Company the Parent Termination Fee by wire\ntransfer (to an account designated by Parent) in immediately available funds within two (2) Business Days after\nsuch termination.\n(b) \u201cParent Termination Fee\u201d shall mean a cash amount equal to $100,377,441.\n(c) Notwithstanding anything in this Agreement to the contrary, the Parties agree that if this Agreement is\nterminated in accordance with any provision under which payment of the Parent Termination Fee is required\nhereunder or is terminated at a time at which this Agreement is then terminable under any provision that would\ntrigger Parent\u2019s obligation to pay the Parent Termination Fee, then, upon receipt of such payment by Company,\n(i) the payment of such Parent Termination Fee in accordance with this Section 7.4, shall be the sole and\nexclusive remedy of the Company for any loss suffered as a result of any breach of any covenant or agreement\nin this Agreement or the failure of the Transactions to be consummated, and (ii) none of the Parent Related\nParties or their Representatives shall have any further liability of any kind for any reason arising out of or in\nconnection with the Transactions. In the event that the Company receives any payments from Parent in respect\nof a breach of this Agreement and thereafter the Company is entitled to receive the Parent Termination Fee\nunder this Section 7.4, the amount of such Parent Termination Fee shall be reduced by the aggregate amount of\nany payments made by Parent to the Company. In no event shall the Company be entitled to more than one\npayment of the full Parent Termination Fee in connection with a termination of this Agreement pursuant to\nwhich such Parent Termination Fee is payable.\n(d) Each of the Parties hereto acknowledges that the Parent Termination Fee is not intended to be a penalty,\nbut rather is liquidated damages in a reasonable amount that will compensate the Company in the circumstances\nin which such Parent Termination Fee is due and payable and which do not involve Fraud or a Willful and\nMaterial Breach, for the efforts and resources expended and opportunities foregone while negotiating this\nAgreement and in reliance on this Agreement and on the expectation of the consummation of the Transactions,\nwhich amount would otherwise be impossible to calculate with precision.\n(e) Each of the Company, Parent and Merger Sub acknowledges that the agreements contained in this Section\n7.4 are an integral part of the Transactions, and that, without these agreements, the Company, Parent and Merger\nSub would not enter into this Agreement. Accordingly, if Parent fails to pay in a timely manner any amount due\npursuant to Section 7.4(a), and, in order to obtain such payment, the Company commences a suit that results in\na judgment against Parent for the amounts set forth in this Section 7.4 or any portion thereof, then (i) the Parent\nshall reimburse the Company for costs and expenses (including disbursements and reasonable fees of counsel)\nincurred in connection with the collection under and enforcement of this Section 7.4 (collectively, \u201cEnforcement\nExpenses\u201d) and (ii) Parent shall pay to the Company interest on such amount from and including the date\npayment of such amount was due to but excluding the date of actual payment at the prime rate set forth in The\nWall Street Journal in effect on the date such payment was required to be made plus two percent (2%)\u037e provided,\nhowever, that in no event shall the Enforcement Expenses payable by the Company, on the one hand, or the\nEnforcement Expenses payable by Parent and Merger Sub, on the other hand, exceed $7.5 million in the\naggregate.\nSection 7.5",
            "Termination Fees\nIf the Merger Agreement is terminated in specified circumstances, Tivity Health or Parent may be required to pay a\ntermination fee.\nParent would be entitled to receive a termination fee of $54,371,114 from Tivity Health if:\n\u2022\nthe Merger Agreement is terminated by Tivity Health to enter into a definitive agreement providing for a\nCompany Superior Proposal\u037e\n\u2022\nthe Merger Agreement is terminated by Parent because a Company Adverse Recommendation Change has\noccurred prior to obtaining the Tivity Health Stockholder Approval\u037e and\n\u2022\n(i) a Company Takeover Proposal has been publicly disclosed by any person after the date of the Merger\nAgreement and not withdrawn prior to a termination of the Merger Agreement as contemplated by its terms\nand thereafter the Merger Agreement is terminated (x) by Parent or Tivity Health because the closing of the\nMerger has not occurred on or prior to the End Date and at the time of such termination the conditions to\nthe parties\u2019 obligations to effect the Merger relating to the absence of legal prohibitions and the expiration\nof applicable waiting periods under the HSR Act have been satisfied, (y) by Parent because of the breach\nof any representation, warranty, covenant or other agreement under the Merger Agreement by Tivity\nHealth, which breach would give rise to the failure of any conditions to the obligations of Parent to effect\nthe Merger or (z) by Parent or Tivity Health if the Tivity Health Stockholder Approval has not been\nobtained upon a vote taken thereon at the Stockholder Meeting or any adjournment or postponement\nthereof, and (ii) at any time on or prior to the 12 month anniversary of such termination, Tivity Health or any\nof its subsidiaries enters into a definitive agreement with respect to any transaction included within the\ndefinition of Company Takeover Proposal that is subsequently consummated (whether within such 12\nmonth period or thereafter)\u037e provided, that for the purposes of this provision, all references in the definition\nof Company Takeover Proposal to 20% will instead be references to 50%.\nTivity Health would be entitled to receive a reverse termination fee of $100,377,441 from Parent in the event the\nMerger Agreement is terminated (i) by Tivity Health because of the breach of any representation, warranty, covenant\nor other agreement under the Merger Agreement by Parent and Merger Sub, which breach would give rise to the\nfailure of any conditions to the obligations of Tivity Health to effect the Merger, (ii) by Tivity Health because of\nParent\u2019s failure to consummate the closing of the Merger within three business days of Tivity Health\u2019s notice of the\nsatisfaction or waiver of all conditions to Parent and Merger Sub\u2019s obligations to effect the Merger, Tivity Health\u2019s\nwillingness and ability to effect the Merger at such time, Tivity Health\u2019s intent to terminate the Merger Agreement, or\n(iii) by Tivity Health or Parent because the closing of the Merger has not occurred on or prior to the End Date and, at\nthe time of such termination, Tivity Health would have been entitled to terminate the Merger Agreement under\nclauses (i) or (ii) above.",
            "Section 7.3 Company Termination Fee.\nA-46TABLE OF CONTENTS\n(a)\u2003(i) If this Agreement is terminated by the Company pursuant to and in accordance with Section 7.1(f), the\nCompany shall pay to Parent the Company Termination Fee, by wire transfer (to an account designated by\nParent) in immediately available funds immediately prior to or concurrently with such termination.\n(ii)\u2003If this Agreement is terminated by Parent pursuant to and in accordance with Section 7.1(h), the\nCompany shall pay to Parent the Company Termination Fee, by wire transfer (to an account designated by\nParent) in immediately available funds within two (2) Business Days after such termination.\n(iii)\u2003If (A) a Company Takeover Proposal shall have been publicly disclosed by any Person after the date\nof this Agreement and not withdrawn prior to a termination of this Agreement as contemplated by this\nSection 7.3(a)(iii) and thereafter this Agreement is terminated (x) by Parent or the Company pursuant to\nSection 7.1(c) and at the time of such termination the conditions set forth in Section 6.1(b) and Section\n6.1(c) have been satisfied, (y) by Parent pursuant to Section 7.1(g) or (z) by Parent or the Company\npursuant to Section 7.1(b) and (B) at any time on or prior to the twelve (12) month anniversary of such\ntermination, the Company or any of its Subsidiaries enters into a definitive agreement with respect to any\ntransaction included within the definition of Company Takeover Proposal that is subsequently\nconsummated (whether within such twelve (12) month period or thereafter), then the Company shall pay\nParent the Company Termination Fee, by wire transfer (to an account designated by Parent) of immediately\navailable funds upon the consummation of such transaction\u037e provided, that for the purposes of this\nSection 7.3(a)(iii), all references in the definition of Company Takeover Proposal to \u201ctwenty percent (20%)\u201d\nshall instead be references to \u201cfifty percent (50%).\u201d\n(b)\u2003\u201cCompany Termination Fee\u201d shall mean a cash amount equal to $54,371,114.\n(c)\u2003Notwithstanding anything in this Agreement to the contrary, the Parties agree that if this Agreement is\nterminated in accordance with any provision under which payment of the Company Termination Fee is required\nhereunder or is terminated at a time at which this Agreement is then terminable under any provision that would\ntrigger the Company\u2019s obligation to pay the Company Termination Fee, then, except in the case of Fraud or a\nWillful and Material Breach occurring prior to such termination, upon receipt of such payment by Parent, (i) the\npayment of such Company Termination Fee in accordance with this Section 7.3, shall be the sole and exclusive\nremedy of Parent and Merger Sub for any loss suffered as a result of any breach of any covenant or agreement\nin this Agreement or the failure of the Transactions to be consummated, and (ii) none of the Company, its\nSubsidiaries or any of their respective former, current or future stockholders, directors, officers, Affiliates,\nagents or other Representatives (collectively, the \u201cCompany Parties\u201d) shall have any further liability of any kind\nfor any reason arising out of or in connection with the Transactions. In the event that Parent or Merger Sub\nreceives any payments from the Company in respect of a breach of this Agreement and thereafter Parent is\nentitled to receive the Company Termination Fee under this Section 7.3, the amount of such Company\nTermination Fee shall be reduced by the aggregate amount of any payments made by the Company to Parent or\nMerger Sub. In no event shall Parent be entitled to more than one payment of the full Company Termination Fee\nin connection with a termination of this Agreement pursuant to which such Company Termination Fee is\npayable.\n(d)\u2003Each of the Parties hereto acknowledges that the Company Termination Fee is not intended to be a penalty,\nbut rather is liquidated damages in a reasonable amount that will compensate Parent in the circumstances in\nwhich such Company Termination Fee is due and payable and which do not involve Fraud or a Willful and\nMaterial Breach, for the efforts and resources expended and opportunities foregone while negotiating this\nAgreement and in reliance on this Agreement and on the expectation of the consummation of the Transactions,\nwhich amount would otherwise be impossible to calculate with precision.\n(e)\u2003Each of the Company, Parent and Merger Sub acknowledges that the agreements contained in this Section\n7.3 are an integral part of the Transactions, and that, without these agreements, the Company, Parent and Merger\nSub would not enter into this Agreement. Accordingly, if the Company fails to pay in a timely manner any\namount due pursuant to Section 7.3(a), and, in order to obtain such payment, Parent or Merger Sub commences\na suit that results in a judgment against the Company for the amounts set forth in this Section 7.3 or any portion\nthereof, then (i) the Company shall reimburse Parent for all costs and expenses (including disbursements and\nreasonable fees of counsel) incurred in connection with the collection under\nA-47\nTABLE OF CONTENTS\nand enforcement of this Section 7.3 and (ii) the Company shall pay to Parent interest on such amount from and\nincluding the date payment of such amount was due to but excluding the date of actual payment at the prime\nrate set forth in The Wall Street Journal in effect on the date such payment was required to be made plus two\npercent (2%).\nSection 7.4",
            "Enforcement Expenses (page 88)\nIf either Tivity Health or Parent fails to pay the termination fee or reverse termination fee, respectively, and in order to\nobtain such payment, Parent or Tivity Health, as applicable, commences a suit that results in a judgment against the\nother party for the payment of such fee, such paying party must reimburse the non-paying party for all costs and\nexpenses (including disbursements and reasonable fees of counsel) incurred in connection with the collection under\nand enforcement under the applicable provisions of the Merger Agreement plus interest. However, neither such\npayment may exceed $7.5 million in the aggregate.\n13TABLE OF CONTENTS"
        ],
        [
            "Legal Proceedings Regarding the Merger (page 66)\nOn May 11, 2022, a purported stockholder of Tivity Health filed a complaint in the United States District Court for the\nSouthern District of New York, captioned Stein v. Tivity Health, Inc., et al., Case No. 1:22-cv-03832 (referred to as the\n\u201cStein Complaint\u201d), naming as defendants Tivity Health and each member of the Board. On May 20, 2022, a purported\nstockholder of Tivity Health filed a complaint in the United States District Court for the Eastern District of New York,\ncaptioned Hopkins v. Tivity Health, Inc., et al., Case No. 1:22-cv-02992 (referred to as the \u201cHopkins Complaint\u201d, and,\ncollectively with the Stein Complaint, the \u201cComplaints\u201d), naming as defendants Tivity Health and each member of the\nBoard.\nThe Complaints allege, among other things, that the defendants violated Section 14(a) and Section 20(a) of the\nExchange Act as well as Rule 14a-9 promulgated thereunder. Specifically, the Complaints allege that the preliminary\nproxy statement filed by Tivity Health with the SEC on May 10, 2022 in connection with the Merger contains\nmaterially incomplete and misleading information concerning the Company\u2019s financial projections and the financial\nanalyses conducted by Lazard in support of its fairness opinion. The relief sought in the Complaints includes\nenjoining the consummation and closing of the Merger unless and until the defendants disclose certain\n7TABLE OF CONTENTS\nallegedly material information\u037e rescinding, to the extent already implemented, the Merger Agreement or any of the\nterms thereof\u037e granting rescissory damages\u037e directing the defendants to account for all alleged damages suffered as a\nresult of the defendants\u2019 alleged wrongdoing\u037e and awarding the plaintiffs\u2019 costs and disbursements, including\nreasonable attorneys\u2019 fees and expenses.\nTivity Health believes that the claims asserted in the Complaints are without merit and Tivity Health and the\nindividual defendants intend to defend against the Complaints\u037e however, Tivity Health cannot predict the amount of\ntime and expense that will be required to resolve either or both of the Complaints, nor the outcomes thereof.\nAdditional lawsuits may be filed against Tivity Health or its directors and officers in connection with the Merger. The\noutcome of any pending or future litigation is uncertain. Such litigation, if not resolved, could prevent or delay\nconsummation of the Merger and result in substantial costs to Tivity Health, including any costs associated with the\nindemnification of directors and officers. One of the conditions to the consummation of the Merger is that no order,\njudgment, or injunction, whether temporary, preliminary or permanent, by any court or other tribunal of competent\njurisdiction has been entered and continues to be in effect, and no law has been adopted or is effective, in each case\nthat restrains, enjoins, prevents, prohibits or makes illegal the consummation of the Merger. Therefore, if a plaintiff\nwere successful in obtaining an injunction prohibiting the consummation of the Merger on the agreed-upon terms,\nthen such injunction may prevent the Merger from being consummated within the expected time frame, or at all.",
            "Legal Proceedings Regarding the Merger\nOn May 11, 2022, a purported stockholder of Tivity Health filed a complaint in the United States District Court for the\nSouthern District of New York, captioned Stein v. Tivity Health, Inc., et al., Case No. 1:22-cv-03832 (referred to as the\n\u201cStein Complaint\u201d), naming as defendants Tivity Health and each member of the Board. On May 20, 2022, a purported\nstockholder of Tivity Health filed a complaint in the United States District Court for the Eastern District of New York,\ncaptioned Hopkins v. Tivity Health, Inc., et al., Case No. 1:22-cv-02992 (referred to as the \u201cHopkins Complaint\u201d, and,\ncollectively with the Stein Complaint, the \u201cComplaints\u201d), naming as defendants Tivity Health and each member of the\nBoard.\nThe Complaints allege, among other things, that the defendants violated Section 14(a) and Section 20(a) of the\nExchange Act as well as Rule 14a-9 promulgated thereunder. Specifically, the Complaints allege that the preliminary\nproxy statement filed by Tivity Health with the SEC on May 10, 2022 in connection with the Merger contains\nmaterially incomplete and misleading information concerning the Company\u2019s financial projections and the financial\nanalyses conducted by Lazard in support of its fairness opinion. The relief sought in the Complaints includes\nenjoining the consummation and closing of the Merger unless and until the defendants disclose certain allegedly\nmaterial information\u037e rescinding, to the extent already implemented, the Merger Agreement or any of the terms\nthereof\u037e granting rescissory damages\u037e directing the defendants to account for all alleged damages suffered as a result\nof the defendants\u2019 alleged wrongdoing\u037e and awarding the plaintiffs\u2019 costs and disbursements, including reasonable\nattorneys\u2019 fees and expenses.\nTivity Health believes that the claims asserted in the Complaints are without merit and Tivity Health and the\nindividual defendants intend to defend against the Complaints\u037e however, Tivity Health cannot predict the amount of\ntime and expense that will be required to resolve either or both of the Complaints, nor the outcomes thereof.\nAdditional lawsuits may be filed against Tivity Health or its directors and officers in connection with the Merger. The\noutcome of any pending or future litigation is uncertain. Such litigation, if not resolved, could prevent or delay\nconsummation of the Merger and result in substantial costs to Tivity Health, including any costs associated with the\nindemnification of directors and officers. One of the conditions to the consummation of the Merger is that no order,\njudgment, or injunction, whether temporary, preliminary or permanent, by any court or other tribunal of competent\njurisdiction has been entered and continues to be in effect, and no law has been adopted or is effective, in each case\nthat restrains, enjoins, prevents, prohibits or makes illegal the consummation of the Merger. Therefore, if a plaintiff\nwere successful in obtaining an injunction prohibiting the consummation of the Merger on the agreed-upon terms,\nthen such injunction may prevent the Merger from being consummated within the expected time frame, or at all.",
            "Section 3.12 Taxes.\n(a) Except as would not have a Company Material Adverse Effect:\n(i) All Tax Returns required by applicable Law to be filed with any Taxing Authority by, or on behalf of,\nthe Company or any of its Subsidiaries have been duly filed when due (including extensions) in accordance\nwith all applicable Laws, and all such Tax Returns are true, correct and complete.\n(ii) Each of the Company and its Subsidiaries has duly and timely paid or has duly and timely withheld\nand remitted to the appropriate Taxing Authority all Taxes required to be paid or withheld and remitted by\nthem, or where payment is being contested in good faith pursuant to appropriate procedures, has\nestablished an adequate reserve in accordance with GAAP reflected in the most recent financial statements\ncontained in the Company SEC Documents filed prior to the date hereof.\n(iii) There is no Proceeding pending or, to the Knowledge of the Company, threatened in writing, against\nor with respect to the Company or any of its Subsidiaries in respect of any Tax.\nA-16TABLE OF CONTENTS\n(iv) There are no Liens for Taxes on any of the assets of the Company or any of its Subsidiaries other\nthan Permitted Liens.\n(v) Neither the Company nor any of its Subsidiaries has granted any waiver of any statute of limitations\nwith respect to, or any extension of a period for the assessment or collection of, any Tax.\n(vi) Neither the Company nor any of its Subsidiaries has constituted either a \u201cdistributing corporation\u201d or\na \u201ccontrolled corporation\u201d (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of\nstock intended to be governed by Section 355 or 361 of the Code in the two (2) years prior to the date of\nthis Agreement.\n(vii) Neither the Company nor any of its Subsidiaries is liable for Taxes of any Person (other than the\nCompany and its Subsidiaries) as a result of being (i) a member of an affiliated, consolidated, combined or\nunitary group that includes such Person as a member, (ii) a transferee or successor of such Person or (iii) a\nparty to a Tax sharing, Tax allocation or Tax indemnity agreement or arrangement with such Person, other\nthan such agreements with customers, vendors, lessors or the like entered into in the ordinary course of\nbusiness and other customary Tax indemnifications contained in credit or other commercial agreements the\nprimary purpose of which agreements does not relate to Taxes.\n(viii) Neither the Company nor any of its Subsidiaries has participated in a \u201clisted transaction\u201d as defined\nin Treasury Regulations Section 1.6011-4(b)(2).\n(b) This Section 3.12 and the Tax-related representations and warranties contained in Section 3.13 contain the\nsole and exclusive representations and warranties of the Company regarding Tax matters, liabilities or\nobligations or compliance with Laws relating thereto.\nSection 3.13"
        ],
        [
            "Section 8.10 Entire Agreement. This Agreement together with the exhibits hereto, schedules and annexes hereto\n(including the Company Disclosure Letter) and the Confidentiality Agreement constitute the entire agreement, and\nsupersede all other prior agreements and understandings, both written and oral, between the Parties, or any of them,\nwith respect to the subject matter hereof and thereof, and except as provided by Section 8.13, this Agreement is not\nintended to grant standing to any Person other than the Parties hereto.\nSection 8.11",
            "Access to Information\nFor the sole purpose of furthering the transactions contemplated by the Merger Agreement and integration planning\nrelated thereto, Tivity Health will upon reasonable advance notice, afford Parent and its representatives (at Parent\u2019s\nand its representatives\u2019 sole cost and expense) reasonable access during normal business hours, throughout the\nperiod prior to the Effective Time, in a manner that does not unreasonably interfere with the business of Tivity Health\nor any of its subsidiaries, to personnel, properties, contracts, books and records (other than any of the foregoing that\nrelate to the negotiation and execution of the Merger Agreement, the process that led to the negotiation and\nexecution of the Merger Agreement or, subject to the disclosure requirements of the relevant provisions of the\nMerger Agreement, any Company Takeover Proposal), and, during such period, Tivity Health will, and will cause its\nsubsidiaries to, without limitation to the preceding obligations, make available to Parent subject to the same terms\nand conditions all other information concerning its business, properties and personnel as Parent may reasonably\nrequest\u037e provided, however, that Tivity Health will be permitted to redact any information or documentation provided\nto the extent that such information or documentation includes competitively sensitive information\u037e and, provided,\nfurther, that Tivity Health may restrict the foregoing access to those persons who have entered into or are bound by\na confidentiality agreement with it.\nNotwithstanding the foregoing, Tivity Health will not be required to provide access to or make available to any\nperson any document or information that, in the reasonable judgment of Tivity Health, (i) would violate any of\n83TABLE OF CONTENTS\nits obligations with respect to any applicable law or order, (ii) would violate any of its material obligations with\nrespect to confidentiality or the terms of any contract or (iii) is subject to any attorney-client or work-product\nprivilege.",
            "Section 5.2 Access.\n(a) For the sole purpose of furthering the Transactions and integration planning related thereto, the Company\nshall upon reasonable advance notice, afford Parent and its Representatives (at Parent\u2019s and its\nRepresentatives\u2019 sole cost and expense) reasonable access during normal business hours, throughout the\nperiod prior to the Effective Time, in a manner that does not unreasonably interfere with the business of the\nCompany or any of its Subsidiaries, to personnel, properties, Contracts, books and records (other than any of\nthe foregoing that relate to the negotiation and execution of this Agreement, the process that led to the\nnegotiation and execution of this Agreement or, subject to the disclosure requirements of Section 5.5, any\nCompany Takeover Proposal), and, during such period, the Company shall, and shall cause its Subsidiaries to,\nwithout limitation to the preceding obligations, make available to Parent subject to the same terms and\nconditions all other information concerning its business, properties and personnel as Parent may reasonably\nrequest\u037e provided, however, that the Company will be permitted to redact any information or documentation\nprovided to the extent that such information or documentation includes competitively sensitive information\u037e\nand, provided, further, that the Company may restrict the foregoing access to those Persons who have entered\ninto or are bound by a confidentiality agreement with it. Notwithstanding the foregoing, the Company shall not\nbe required to provide access to or make available to any Person any document or information that, in the\nreasonable judgment of the Company, (i) would violate any of its obligations with respect to any applicable Law\nor Order, (ii) would violate any of its material obligations with respect to confidentiality or the terms of any\nContract or (iii) is subject to any attorney-client or work-product privilege. All requests for access or information\nmade pursuant to this Section 5.2(a) shall be directed to an executive officer or other Person designated by the\nCompany. Notwithstanding anything to the contrary herein, the Company may satisfy its obligations set forth\nabove by electronic means if physical access is not reasonably feasible or would not be permitted under the\napplicable Law (including as a result of COVID-19 or any COVID-19 Measures).\n(b) In conducting any inspection of any properties of the Company and its Subsidiaries, Parent and its\nRepresentatives shall not damage any property or any portion thereof. Prior to the Effective Time, Parent and its\nRepresentatives shall not have the right to conduct environmental testing or sampling at any of the facilities or\nproperties of the Company or any of its Subsidiaries.\n(c) No investigation by Parent or its Representatives shall affect or be deemed to modify or waive the\nrepresentations and warranties of the Company set forth in this Agreement. No rights under this Section 5.2 can\nbe exercised by Parent or any of its Representatives to prepare for, or otherwise in connection with, any Action\nrelating to this Agreement.\n(d) The Parties hereto hereby agree that all information provided to them or their respective Representatives in\nconnection with this Agreement and the consummation of the Transactions shall be governed in accordance\nwith the confidentiality agreement, dated December 30, 2021 (the \u201cConfidentiality Agreement\u201d), between the\nCompany and Parent.\nSection 5.3",
            "Section 3.15 Intellectual Property.\n(a) Except as would not have a Company Material Adverse Effect, the Company or a Subsidiary of the\nCompany exclusively owns all Company Intellectual Property, and is licensed or otherwise possesses adequate\nrights to use all other Intellectual Property used in connection with or necessary for the business of the\nCompany and its Subsidiaries as currently conducted, in each case, free and clear of all Liens, other than\nPermitted Liens.\n(b) Except as set forth on Section 3.15(b) of the Company Disclosure Letter and except as would not have a\nCompany Material Adverse Effect, (i) to the Knowledge of the Company, the conduct of the business\nconducted by the Company and its Subsidiaries does not infringe, misappropriate, or otherwise violate, and\nsince December 31, 2019, has not infringed, misappropriated, or otherwise violated, any Person\u2019s Intellectual\nProperty, and there is no such claim pending or, to the Knowledge of the Company, threatened, against the\nCompany or its Subsidiaries\u037e and (ii) to the Knowledge of the Company, no Person is infringing,\nmisappropriating or otherwise violating any Company Intellectual Property and no such claims are pending or\nthreatened against any Person by the Company or its Subsidiaries.\nA-19TABLE OF CONTENTS\n(c) Section 3.15(c) of the Company Disclosure Letter contains for the Company Intellectual Property an\naccurate and complete list of the patents, pending patent applications, registered copyrights, pending copyright\nregistrations, registered trademarks, and pending applications for registration of trademarks owned by the\nCompany or any of its Subsidiaries (referred to collectively as the \u201cCompany Registered Intellectual Property\u201d),\nand all of which are, to the Knowledge of the Company, valid and enforceable. No registrations or applications\nfor Company Registered Intellectual Property have expired or been cancelled or abandoned, except (i) in\naccordance with the expiration of the term of such rights, (ii) intentional cancellations and abandonments in the\nordinary course of business, or (iii) as would not have a Company Material Adverse Effect.\n(d) Except as would not have a Company Material Adverse Effect, the Company and its Subsidiaries have\ntaken reasonable measures to protect the confidentiality of the trade secrets of the Company and its\nSubsidiaries.\n(e) Except as would not have a Company Material Adverse Effect, (i) the Company and its Subsidiaries\nmaintain and enforce commercially reasonable policies, procedures and rules regarding data privacy, protection\nand security as required under applicable Laws, and (ii) the Company and its Subsidiaries are, and at all times\nsince December 31, 2019 have been, in compliance with all Data Security Requirements. To the Knowledge of the\nCompany, since December 31, 2019, there have been no (A) actual incidents of security breaches or\nunauthorized access or use of any of the IT Assets or trade secrets of the Company or any of its Subsidiaries or\n(B) actual unauthorized access to or collection, use, processing, storage, sharing, distribution, transfer,\ndisclosure, destruction or disposal of any such trade secrets or other confidential information, in each case\nexcept as would not have a Company Material Adverse Effect.",
            "Alternative Acquisition Agreements (page 77)\nExcept as described in the following paragraph, under the terms of the Merger Agreement, none of Tivity Health, its\nsubsidiaries or any of their respective directors and officers may execute or enter into, any binding letter of intent,\nacquisition agreement, merger agreement, joint venture agreement or similar contract, whether written, oral, binding or\nnon-binding, with respect to a Company Takeover Proposal (other than a confidentiality agreement).\nUnder the Merger Agreement, prior to, but not after, obtaining the affirmative vote of a majority of the outstanding\nshares of Tivity Health Common Stock entitled to vote thereon (the \u201cTivity Health Stockholder Approval\u201d), under\ncertain circumstances and subject to certain requirements described in the section entitled \u201cTerms of the Merger\nAgreement-Alternative Acquisition Agreements\u201d beginning on page 77 of this Proxy Statement, the Board is entitled\nto, with respect to a Company Superior Proposal, either or both: (1) make a Company Adverse Recommendation\nChange (as defined in the section entitled \u201cTerms of the Merger Agreement-",
            "Section 5.9 Public Announcements. Unless a Company Adverse Recommendation Change has occurred, the Parties\nshall consult with one another prior to issuing, and provide each other with the opportunity to review and comment\nupon, any public announcement, statement or other disclosure with respect to this Agreement or the Transactions\nand shall not issue any such public announcement or statement prior to such consultation, except as may be required\nby Law or by the rules and regulations of Nasdaq\u037e provided, that each of the Company and Parent may make any\npublic statements in response to questions by the press, analysts, investors or analyst or investor calls, so long as\nsuch statements are not inconsistent with previous statements made jointly by the Company and Parent (or made by\none Party after having consulted with the other Party)\u037e provided, further, that the Company need not consult with\nParent, and Parent need not consult with the Company, in connection with any public announcement, statement or\nother disclosure with respect to any Company Takeover Proposal (including any \u201cstop, look and listen\u201d\ncommunication), Company Superior Proposal, Company Adverse Recommendation Change or dispute among the\nParties regarding this Agreement. The Company and Parent agree to issue a joint press release announcing the\nexecution and delivery of this Agreement\u037e provided, further, that Parent, Merger Sub and their respective Affiliates\nmay, without consultation or consent, make ordinary course disclosure and communication to existing or prospective\ngeneral or limited partners, equity holders, members, managers and investors of such Person or any Affiliates of such\nPerson, in each case who are subject to customary confidentiality restrictions.\nSection 5.10",
            "Annex A\nThe Merger Agreement has been included to provide investors with information regarding its terms. It is not\nintended to provide any other factual information about Tivity Health, Parent, Merger Sub, and Stone Point\nCapital or their respective subsidiaries or affiliates. The representations, warranties and covenants contained in\nthe Merger Agreement were made only for purposes of the Merger Agreement as of the specific dates therein,\nwere solely for the benefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by\nthe contracting parties, including being qualified by confidential disclosures made for the purposes of allocating\ncontractual risk among the parties to the Merger Agreement instead of establishing these matters as facts, and\nmay be subject to standards of materiality applicable to the contracting parties that differ from those applicable\nto investors. Investors should not rely on the representations, warranties and covenants or any descriptions\nthereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective\nsubsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties\nmay change after April 5, 2022, which subsequent information may or may not be reflected in Tivity Health\u2019s\npublic disclosures. Accordingly, the representations, warranties, covenants and other agreements in the Merger\nAgreement should not be read alone, and you should read the information provided elsewhere in this document\nand in our filings with the SEC regarding Tivity Health and its business. Please see the section entitled \u201cWhere\nYou Can Find More Information\u201d beginning on page 101 of this Proxy Statement.\nAGREEMENT AND PLAN OF MERGER\n \nby and among\n \nTITAN-ATLAS PARENT, INC.,\n \nTITAN-ATLAS MERGER SUB, INC.,\n \nand\n \nTIVITY HEALTH, INC.\n \nDated as of April 5, 2022\nA-1TABLE OF CONTENTS\nTABLE OF CONTENTS",
            "Restrictions on Solicitations of Other Offers (page 75)\nFor purposes of this Proxy Statement, each of \u201cCompany Takeover Proposal\u201d and \u201cCompany Superior Proposal\u201d is\ndefined in the section entitled \u201cTerms of the Merger Agreement-Restrictions on Solicitations of Other Offers\u201d\nbeginning on page 75 of this Proxy Statement.\nIn the Merger Agreement, Tivity Health agreed that, subject to certain exceptions, Tivity Health will not, and will\ncause its subsidiaries and its and their respective directors and officers not to, and will instruct and use its\nreasonable best efforts to cause its and its subsidiaries other representatives not to, directly or indirectly through\nintermediaries: (i) solicit, initiate, or knowingly encourage the making of any proposal or offer that constitutes, or\nwould reasonably be expected to lead to, a Company Takeover Proposal\u037e (ii) conduct, engage in, continue or\notherwise participate in negotiations or discussions regarding, or furnish to any other person any information in\nconnection with, or for the purpose of knowingly encouraging, a Company Takeover Proposal\u037e (iii) execute or enter\ninto any binding letter of intent, acquisition agreement, merger agreement, joint venture agreement or similar contract,\nwhether written, oral, binding or non-binding, with respect to a Company Takeover Proposal\u037e or (iv) grant any waiver,\namendment or release of any third party under any standstill or confidentiality agreement. However, Tivity Health\nmay grant a waiver of any standstill or similar obligation of any third party with respect to Tivity Health or any of its\nsubsidiaries to allow such third party to make a Company Takeover Proposal.",
            "Explanatory Note Regarding the Merger Agreement\nThe following description of the Merger Agreement does not purport to be complete and is qualified in its entirety by\nreference to the full text of the Merger Agreement, which is included as Annex A hereto. The Merger Agreement has\nbeen included to provide investors with information regarding its terms. It is not intended to\n66TABLE OF CONTENTS\nprovide any other factual information about Tivity Health, Parent, Merger Sub, and Stone Point Capital or their\nrespective subsidiaries or affiliates. The representations, warranties and covenants contained in the Merger\nAgreement were made only for purposes of the Merger Agreement as of the specific dates therein, were solely for the\nbenefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties,\nincluding being qualified by confidential disclosures made for the purposes of allocating contractual risk among the\nparties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of\nmateriality applicable to the contracting parties that differ from those applicable to investors. Investors should not\nrely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual\nstate of facts or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover,\ninformation concerning the subject matter of representations and warranties may change after April 5, 2022, which\nsubsequent information may or may not be reflected in Tivity Health\u2019s public disclosures. Accordingly, the\nrepresentations, warranties, covenants and other agreements in the Merger Agreement should not be read alone, and\nyou should read the information provided elsewhere in this document and in our filings with the SEC regarding Tivity\nHealth and its business. Please see the section entitled \u201cWhere You Can Find More Information\u201d beginning on page\n101 of this Proxy Statement.",
            "Adverse Recommendation Changes\nAs described above, and subject to the provisions described below, the Board has made the recommendation that\nTivity Health stockholders vote \u201cFOR\u201d the proposal to adopt the Merger Agreement (the \u201cCompany Board\nRecommendation\u201d). The Merger Agreement provides that the Board will not effect a Company Adverse\nRecommendation Change (as defined below) except as described below.\nUnder the terms of the Merger Agreement, the Board may not:\n\u2022\n(i) fail to include the Company Board Recommendation in this Proxy Statement when it is disseminated to\nTivity Health\u2019s stockholders, (ii) withhold, withdraw or modify, or authorize or publicly propose to withhold,\nwithdraw or modify, in any such case in a manner adverse to Parent, the Company Board Recommendation,\n(iii) publicly make any recommendation in support of a tender offer or exchange offer that constitutes a\nCompany Takeover Proposal or fail to recommend against any such tender offer or exchange offer, (iv)\npublicly adopt, approve or recommend, or publicly propose to adopt, approve or recommend, to\nstockholders of Tivity Health a Company Takeover Proposal or (v) fail to publicly recommend against any\nCompany Takeover Proposal or fail to publicly reaffirm the Company Board Recommendation, in each case,\nwithin five business days after Parent so requests in writing following a publicly announced Company\nTakeover Proposal, provided that Parent may only make such request once with respect to any particular\nCompany Takeover Proposal or any material publicly announced or disclosed amendment or modification\nthereto (any action described in this clause being referred to as a \u201cCompany Adverse Recommendation\nChange\u201d)\u037e or\n\u2022\nauthorize, cause or permit Tivity Health or any of its subsidiaries to enter into any binding letter of intent,\nmemorandum of understanding or agreement, including an acquisition agreement, merger agreement, joint\nventure agreement or other agreement, with respect to any Company Takeover Proposal (other than an\nAcceptable Confidentiality Agreement as defined in the Merger Agreement).\nNotwithstanding anything in the Merger Agreement to the contrary, other than in connection with a Company\nTakeover Proposal (as discussed above), the Board may, at any time prior to, but not after, obtaining the Tivity Health\nStockholder Approval, make a Company Adverse Recommendation Change in response to an event, development or\nchange in circumstances that was not known to the Board (or if known, the consequences of which were not known\nto the Board) as of or prior to April 5, 2022, which event, development or change in circumstances becomes known to\nthe Board prior to the Stockholder Meeting (an \u201cIntervening Event\u201d), if, prior to taking such action, the Board has\ndetermined in good faith, after consultation with its financial advisor and outside legal counsel, that the failure to take\nsuch action is reasonably likely to be inconsistent with the directors\u2019 fiduciary duties under applicable law\u037e provided,\nhowever, that, prior to taking such action:\n\u2022\nTivity Health has given Parent at least four business days\u2019 prior written notice of its intention to take such\naction, and specifying in reasonable detail the Intervening Event and the potential reasons that the Board\nis proposing to effect a Company Adverse Recommendation Change\u037e\n\u2022\nto the extent requested in writing by Parent, Tivity Health has negotiated, and has caused its\nrepresentatives to negotiate, in good faith with Parent during such four business day period to enable\nParent to propose revisions to the terms of the Merger Agreement such that it would cause the Board to\nnot make such Company Adverse Recommendation Change\u037e and\n\u2022\nfollowing the end of such four business days\u2019 period, the Board has considered in good faith any revisions\nto the terms of the Merger Agreement to which Parent has committed in writing, and will\n78TABLE OF CONTENTS\nhave determined, after consultation with its financial advisor and outside legal counsel, assuming the\nrevisions committed to by Parent in writing were to be given effect, that the failure to make a Company\nAdverse Recommendation Change is reasonably likely to be inconsistent with the directors\u2019 fiduciary\nduties under applicable law.\nThe Merger Agreement does not restrict Tivity Health or the Board from complying with its disclosure obligations\nunder federal or state law with regard to a Company Takeover Proposal, including (i) taking and disclosing to the\nstockholders of Tivity Health a position contemplated by Rule 14e-2(a), Rule 14d-9 or Item 1012(a) of Regulation MA\npromulgated under the Exchange Act or (ii) making any \u201cstop, look and listen\u201d communication to the stockholders of\nTivity Health pursuant to Rule 14d-9(f) under the Exchange Act if, in either case, the Board determines in good faith,\nafter consultation with outside legal counsel, that the failure to do so is reasonably likely to be inconsistent with the\ndirectors\u2019 fiduciary duties under applicable law or obligations of Tivity Health or the Board under applicable federal\nsecurities law."
        ]
    ]
}